Antibody data
- Antibody Data
- Antigen structure
- References [9]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN1383672 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Interleukin-6 Receptor (IL6R) antibody
- Antibody type
- Monoclonal
- Antigen
- Other
- Reactivity
- Human
- Isotype
- IgG
- Antibody clone number
- B-R6
- Vial size
- 200 µl
- Concentration
- 200µg/200µl
- Storage
- 2-8°C
Submitted references Gp130 and ras mediated signaling in human plasma cell line INA-6: a cytokine-regulated tumor model for plasmacytoma.
STAT3 is constitutively activated in Hodgkin cell lines.
IL-4 prevents the blockade of dendritic cell differentiation induced by tumor cells.
Agonist anti-gp130 transducer monoclonal antibodies are human myeloma cell survival and growth factors.
Toward a role of dendritic cells in the germinal center reaction: triggering of B cell proliferation and isotype switching.
Critical role of IL-12 in dendritic cell-induced differentiation of naive B lymphocytes.
Inhibition of the differentiation of dendritic cells from CD34(+) progenitors by tumor cells: role of interleukin-6 and macrophage colony-stimulating factor.
Pattern of cytokine receptors expressed by human dendritic cells migrated from dermal explants.
Purification and characterization of the soluble interleukin-6 receptor from human plasma and identification of an isoform generated through alternative splicing.
Burger R, Guenther A, Bakker F, Schmalzing M, Bernand S, Baum W, Duerr B, Hocke GM, Steininger H, Gebhart E, Gramatzki M
The hematology journal : the official journal of the European Haematology Association / EHA 2001;2(1):42-53
The hematology journal : the official journal of the European Haematology Association / EHA 2001;2(1):42-53
STAT3 is constitutively activated in Hodgkin cell lines.
Kube D, Holtick U, Vockerodt M, Ahmadi T, Haier B, Behrmann I, Heinrich PC, Diehl V, Tesch H
Blood 2001 Aug 1;98(3):762-70
Blood 2001 Aug 1;98(3):762-70
IL-4 prevents the blockade of dendritic cell differentiation induced by tumor cells.
Menetrier-Caux C, Thomachot MC, Alberti L, Montmain G, Blay JY
Cancer research 2001 Apr 1;61(7):3096-104
Cancer research 2001 Apr 1;61(7):3096-104
Agonist anti-gp130 transducer monoclonal antibodies are human myeloma cell survival and growth factors.
Gu ZJ, De Vos J, Rebouissou C, Jourdan M, Zhang XG, Rossi JF, Wijdenes J, Klein B
Leukemia 2000 Jan;14(1):188-97
Leukemia 2000 Jan;14(1):188-97
Toward a role of dendritic cells in the germinal center reaction: triggering of B cell proliferation and isotype switching.
Dubois B, Barthélémy C, Durand I, Liu YJ, Caux C, Brière F
Journal of immunology (Baltimore, Md. : 1950) 1999 Mar 15;162(6):3428-36
Journal of immunology (Baltimore, Md. : 1950) 1999 Mar 15;162(6):3428-36
Critical role of IL-12 in dendritic cell-induced differentiation of naive B lymphocytes.
Dubois B, Massacrier C, Vanbervliet B, Fayette J, Brière F, Banchereau J, Caux C
Journal of immunology (Baltimore, Md. : 1950) 1998 Sep 1;161(5):2223-31
Journal of immunology (Baltimore, Md. : 1950) 1998 Sep 1;161(5):2223-31
Inhibition of the differentiation of dendritic cells from CD34(+) progenitors by tumor cells: role of interleukin-6 and macrophage colony-stimulating factor.
Menetrier-Caux C, Montmain G, Dieu MC, Bain C, Favrot MC, Caux C, Blay JY
Blood 1998 Dec 15;92(12):4778-91
Blood 1998 Dec 15;92(12):4778-91
Pattern of cytokine receptors expressed by human dendritic cells migrated from dermal explants.
Larregina AT, Morelli AE, Kolkowski E, Sanjuan N, Barboza ME, Fainboim L
Immunology 1997 Jun;91(2):303-13
Immunology 1997 Jun;91(2):303-13
Purification and characterization of the soluble interleukin-6 receptor from human plasma and identification of an isoform generated through alternative splicing.
Müller-Newen G, Köhne C, Keul R, Hemmann U, Müller-Esterl W, Wijdenes J, Brakenhoff JP, Hart MH, Heinrich PC
European journal of biochemistry / FEBS 1996 Mar 15;236(3):837-42
European journal of biochemistry / FEBS 1996 Mar 15;236(3):837-42
No comments: Submit comment
No validations: Submit validation data